Prof. Dr. Mogana Sundari, Director of Research and Development, AKATI Sekurity
Prof. Dr. Mogana S. Rajagopal is an accomplished professional who balances her expertise in cybersecurity research with a strategic role in pharmaceutical sciences. As the Director of Research and Development at AKATI Sekurity, she leads innovative cybersecurity research initiatives. Concurrently, she serves as the Dean at the Faculty of Pharmaceutical Sciences, UCSI University, where she has made significant contributions to education and research in pharmacy.
In her role as the Director of Research and Development at AKATI Sekurity, a Managed Security Services Provider (MSSP), Rajagopal leads cutting-edge cybersecurity research on security implications of new age technologies. Under her guidance, the R&D team at AKATI Sekurity focuses on innovative approaches to protect clients' data and infrastructure, ensuring robust defense mechanisms against cyber attacks. Her key focus areas include the implications of cybersecurity on neuroscience and cybersecurity in health sciences, emphasizing the safeguarding of sensitive medical information and health systems. She also leads AKATI Sekurity’s research on dark web monitoring, aiming to detect and mitigate threats emerging from the clandestine online environment.
Rajagopal also plays a pivotal role in helping AKATI Security collaborate with academia, industry partners, and government agencies to advance cybersecurity knowledge and practices. Her efforts have positioned AKATI Sekurity as a research-focused service provider, known for its comprehensive security solutions and proactive measures against cyber threats. By integrating her expertise in research and development with her commitment to ethical practices, she ensures that AKATI Sekurity remains at the forefront of cybersecurity innovation, safeguarding clients' interests and contributing to the broader goal of a secure digital environment.
As Dean at the Faculty of Pharmaceutical Sciences, UCSI University, Rajagopal has made significant contributions to pharmaceutical education and research. As a registered pharmacist with a focus on phytopharmacology and phytochemistry, she has dedicated her career to natural product drug discovery, particularly in women's health issues such as uterine fibroids, cervical cancer, ovarian cancer, primary dysmenorrhea, and ovarian cysts. Her extensive research portfolio, supported by over $2.5 million in grants, includes over 65 international peer-reviewed publications, two patents, two trademarks, and one trade secret, underscoring her role as a leading figure in this space.